News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
588 Results
Type
Article (60)
Press Release (528)
Section
Business (221)
Deals (30)
Drug Development (94)
FDA (3)
Job Trends (6)
News (297)
Policy (16)
Tag
Academia (2)
Alliances (41)
Alzheimer's disease (1)
Approvals (4)
Best Places to Work (4)
Cancer (5)
CDMO (1)
Clinical research (98)
Collaboration (1)
COVID-19 (10)
C-suite (6)
Data (25)
Depression (1)
Diagnostics (2)
Earnings (15)
ESMO (2)
Events (97)
Executive appointments (2)
FDA (7)
Funding (8)
Gene editing (1)
GLP-1 (3)
Government (2)
Healthcare (34)
Hematology (1)
Infectious disease (10)
Inflammatory bowel disease (1)
IPO (21)
Job creations (2)
Layoffs (1)
Legal (3)
Lung cancer (1)
Medical device (2)
Medtech (2)
Mergers & acquisitions (10)
Neuropsychiatric disorders (1)
Neuroscience (4)
NextGen: Class of 2026 (14)
Non-profit (2)
Pancreatic cancer (1)
Patient recruitment (3)
Patient selection (1)
People (121)
Phase 1 (47)
Phase 2 (54)
Phase 3 (15)
Pipeline (18)
Preclinical (17)
Rare diseases (1)
Real estate (3)
Regulatory (15)
Research institute (4)
Schizophrenia (2)
Series A (2)
Series B (4)
Startups (17)
Venture capital (2)
Date
Last 30 days (5)
Last 365 days (36)
2026 (31)
2025 (37)
2024 (40)
2023 (31)
2022 (59)
2021 (73)
2020 (43)
2019 (68)
2018 (44)
2017 (37)
2016 (34)
2015 (33)
2014 (9)
2013 (8)
2012 (5)
2011 (7)
2010 (5)
Location
Asia (9)
California (1)
Delaware (1)
Europe (16)
Massachusetts (76)
Minnesota (1)
New York (2)
Northern California (1)
Pennsylvania (1)
United States (81)
Virginia (1)
588 Results for "puretech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PureTech Founded Entity Celea Therapeutics Appoints Paul Audhya, MD, MBA, as Chief Medical Officer
October 29, 2026
·
5 min read
Press Releases
PureTech Presents Phase 1b Results for LYT-200 in Relapsed/Refractory (R/R) High-Risk Myelodysplastic Syndromes (HR-MDS) and Acute Myeloid Leukemia (AML) at ESMO 2026
October 26, 2026
·
8 min read
Press Releases
PureTech Health: Notice of Results
April 13, 2026
·
2 min read
Press Releases
PureTech Announces Presentation of Phase 1b Results for LYT-200 in Relapsed/Refractory (R/R) High-Risk Myelodysplastic Syndromes (HR-MDS) and Acute Myeloid Leukemia (AML) at ESMO 2026
October 19, 2026
·
3 min read
Press Releases
PureTech Founded Entity Celea Therapeutics to Deliver Two Presentations at the Upcoming European Respiratory Society (ERS) Congress
August 25, 2026
·
8 min read
Press Releases
PureTech Founded Entity Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39th European College of Neuropsychopharmacology (ECNP) Congress
October 12, 2026
·
13 min read
Press Releases
PureTech Founded Entity Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of GlyphAllo™ in Healthy Volunteers
September 9, 2026
·
12 min read
Press Releases
PureTech Founded Entity Seaport Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial Evaluating GlyphAgo™ in Patients with Generalized Anxiety Disorder and Sleep Disturbance
October 7, 2026
·
14 min read
Press Releases
PureTech Announces Annual Results for Year Ended December 31, 2025
April 29, 2026
·
19 min read
Press Releases
PureTech to Showcase Deupirfenidone Program at the American Thoracic Society International Conference
May 13, 2026
·
7 min read
1 of 59
Next
